Black Diamond Therapeutics shares owned by Acadian Asset Management
Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Acadian Asset Management
from 13F filings
Historical chart of Acadian Asset Management investment in Black Diamond Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Black Diamond Therapeutics held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Black Diamond Therapeutics by Acadian Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.8M | 481k | 3.78 |
| 2025-03-31 | $23k | 15k | 1.54 |
| 2024-12-31 | $42k | 20k | 2.08 |
| 2024-03-31 | $864k | 171k | 5.07 |
| 2023-06-30 | $268k | 53k | 5.02 |
| 2023-03-31 | $99k | 53k | 1.86 |
| 2022-12-31 | $95k | 53k | 1.78 |